Erytech Pharma S.A.(ERYP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ERYP Erytech Pharma S.A.

Market Closed 06-28 16:00:00 EDT

0.7800

+0.0000

0.00%

High0.7800	Low0.7800	Vol0.00
Open0.7800	D1 Closing0.7800	Amplitude0.00%
Mkt Cap26.61M	Tradable Cap24.01M	Total Shares34.12M
T/O2.73K	T/O Rate0.00%	Tradable Shares30.78M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ERYP","market":"US","secType":"STK","nameCN":"Erytech Pharma S.A.","latestPrice":0.78,"timestamp":1687982400000,"preClose":0.78,"halted":8,"volume":0,"delay":0,"floatShares":30784110,"shares":34117798,"eps":-0.010687,"marketStatus":"Market Closed","change":0,"latestTime":"06-28 16:00:00 EDT","open":0.78,"high":0.78,"low":0.78,"amount":2727.218343,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.010687,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731920400000},"marketStatusCode":7,"symbolChange":{"newSymbol":"PHXM","executeDate":"2023-06-29"},"adr":1,"adrRate":1,"listingDate":1510290000000,"exchange":"NASDAQ","adjPreClose":0.78,"volumeRatio":0},"requestUrl":"/m/hq/s/ERYP/tweets","defaultTab":"tweets","newsList":[{"id":"2347878231","title":"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM","url":"https://stock-news.laohu8.com/highlight/detail?id=2347878231","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2347878231?lang=en_us&edition=fundamental","pubTime":"2023-06-29 04:05","pubTimestamp":1687982700,"startTime":"0","endTime":"0","summary":"Lyon  and Cambridge , June 28, 2023 - Phaxiam Therapeutics , announces change of the mnemonic code of its share from ERYP to PHXM, following the merger between ERYTECH and PHERECYDES. The change has been notified by Euronext and will be effective from June 29, 2023.PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.PPHAXIAM is listed on the Nasdaq Capital Market in the United States  and on the Euronext regulated market in Paris . PHAXIAM is part of the CAC Healthcare, CAC Pharma & Bio, CAC Mid & Small, CAC All Tr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/m01eaQ1.2ZmGtGSEilv.zw--~B/aD01MTA7dz0yMzY0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/007521c8c30334165df69158acb50dd3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/m01eaQ1.2ZmGtGSEilv.zw--~B/aD01MTA7dz0yMzY0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/007521c8c30334165df69158acb50dd3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phaxiam-therapeutics-announces-mnemonic-code-200500209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP","PHXM"],"gpt_icon":0},{"id":"2346462852","title":"Monthly information related to total number of voting rights and shares composing the share capital - June 26, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2346462852","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2346462852?lang=en_us&edition=fundamental","pubTime":"2023-06-28 00:00","pubTimestamp":1687881600,"startTime":"0","endTime":"0","summary":"Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France. Listing markets: Euronext Paris from Euronext  & Nasdaq Global Select Market in the United-States Website : www.erytech.com. Gross voting rights number  is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.Without treasury shares.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/m01eaQ1.2ZmGtGSEilv.zw--~B/aD01MTA7dz0yMzY0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/007521c8c30334165df69158acb50dd3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/m01eaQ1.2ZmGtGSEilv.zw--~B/aD01MTA7dz0yMzY0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/007521c8c30334165df69158acb50dd3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monthly-information-related-total-number-160000169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ERYP","BK4139","PHXM"],"gpt_icon":0},{"id":"2346002859","title":"ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2346002859","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2346002859?lang=en_us&edition=fundamental","pubTime":"2023-06-27 22:04","pubTimestamp":1687874697,"startTime":"0","endTime":"0","summary":"ERYTECH (NASDAQ:ERYP) and PHERECYDES announced on Tuesday merger and name change to PHAXIAM Therapeutics.\nPress Release","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/3983220-erytech-and-pherecydes-announce-merger-and-name-change-to-phaxiam-therapeutics","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["QQQ",".IXIC","SQQQ","QLD","TQQQ","ERYP","QID","PSQ","PHXM","BK4139","MNQmain","NQmain"],"gpt_icon":0},{"id":"2345706116","title":"ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2345706116","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2345706116?lang=en_us&edition=fundamental","pubTime":"2023-06-24 04:30","pubTimestamp":1687552200,"startTime":"0","endTime":"0","summary":"ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023. All resolutions voted with a large majority according to Board of Directors recommendations. Company renamed Phaxiam Therapeutics, creating a world leader in phage therapy. Lyon , June 23, 2023 – ERYTECH Pharma  announced today that all resolutions for which the Board of Directors recommended a vote in favor, including the approval of the merger with Pherecydes, were adopted by its shareholders at the Combined General Meeting that was held today, June 23, 2023. Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2022;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2022 to Gil BEYEN and Jean-Paul KRESS and of th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-announces-approval-merger-pherecydes-203000258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ERYP","PHXM","BK4139"],"gpt_icon":0},{"id":"2345268777","title":"ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2345268777","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2345268777?lang=en_us&edition=fundamental","pubTime":"2023-06-21 04:05","pubTimestamp":1687291500,"startTime":"0","endTime":"0","summary":"Cambridge, MA  and Lyon , June 20, 2023 – ERYTECH Pharma  announces the filing of a new lawsuit by Akkadian Partners.Despite the rejection by the President of the Lyon Commercial Court of Akkadian Partners' request to postpone the General Meeting's vote on the proposed merger, Akkadian has initiated new legal proceedings with the clear aim of continuing its attempt to destabilize Erytech.As part of this new procedure, the first hearing of which will take place after the vote on the merger, Akkadian Partners is requesting the cancellation of the capital increase of May 15, 2023. This capital increase, resulting from contributions in kind of Pherecydes shares in exchange for ERYTECH shares, had been announced at the time of the merger announcement last February and had been carried out in accordance with the delegation of authority granted by the 2022 extraordinary general meeting of ERYTECH shareholders under resolution 29 and on the basis of reports issued by Finexsi, acting as a contr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-announces-akkadian-continuing-attempt-200500905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ERYP","BK4139"],"gpt_icon":0},{"id":"2343917962","title":"Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2343917962","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2343917962?lang=en_us&edition=fundamental","pubTime":"2023-06-15 02:03","pubTimestamp":1686765801,"startTime":"0","endTime":"0","summary":"Pherecydes Pharma SA :Reg-Erytech Announces That The Commercial Court Has Rejected Akkadian'S Request To Postpone The Vote On The Merger With Pherecydes Pharma.Erytech Pharma Sa - Erytech Shareholders Will Be Able To Legitimately Vote On Merger On June 23, 2023.Erytech Pharma Sa - Expert Has Been Appointed To Examine Merger Parity And Must Submit His Report To Parties Within 4 Months.Erytech Pharma Sa - Akkadian Partners Has To Cover Costs Of This Expert Appraisal.Erytech Pharma Sa - Akkadian Partners Has Also Been Ordered To Indemnify Erytech For Costs Incurred By Company In This Procedure.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERYP","BK4139"],"gpt_icon":0},{"id":"2343496260","title":"ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2343496260","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2343496260?lang=en_us&edition=fundamental","pubTime":"2023-06-15 02:00","pubTimestamp":1686765600,"startTime":"0","endTime":"0","summary":"ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma. Cambridge, MA  and Lyon , June 14, 2023, 8:00 pm CEST – ERYTECH Pharma , announced today that the Lyon Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma.Erytech is pleased with today's order delivered by the President of the Lyon Commercial Court. This order rejected Akkadian Partners' attempt to postpone the vote on the merger. As a result, Erytech shareholders will be able to legitimately vote on the merger on June 23, 2023.An expert has been appointed to examine the merger parity and must submit his report to the parties within 4 months. Akkadian Partners has to cover the costs of this expert appraisal. Akkadian Partners has also been ordered to indemnify Erytech for the costs incurred by the company in this procedure.On February 15, 2023, ERYTECH announced its intended strategic combination wi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-announces-commercial-court-rejected-180000266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2343674049","title":"Erytech's Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes Closer","url":"https://stock-news.laohu8.com/highlight/detail?id=2343674049","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2343674049?lang=en_us&edition=fundamental","pubTime":"2023-06-14 04:34","pubTimestamp":1686688469,"startTime":"0","endTime":"0","summary":"In February,Erytech Pharma SAannouncedits proposed combination withPherecydes Pharma S.A.In June, Erytech announced that Akkadian initiated proceedings to postpone thevote, scheduled on 23 June, on the merger with Pherecydes.The merger would see Pherecydes absorbed into publicly listed Erytech, with Pherecydes shareholders receiving 15 new Erytech shares for every four of their current shares.Monday,Erytech Pharmaresponded to what it described as Akkadian Partners' \"disinformation,\" arguing that the investor's challenge to the merger was \"based on incomplete information and misleading arguments.\". Erytech warned its shareholders that derailing the merger would risk destroying the value of both companies.\"To the best of our knowledge, Akkadian's predation of Erytech's corporate structure and cash will not support ideas of sufficient quality and robustness to create value for the company and its shareholders, on the contrary,\" the companysaidin its SEC filing.\"This is yet another example","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/O9q.XphUiv6SI7cs1DiyVA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/2b5832b0ad617efb9a599b8d0d771d83","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/O9q.XphUiv6SI7cs1DiyVA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/2b5832b0ad617efb9a599b8d0d771d83"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytechs-battle-activist-investor-echoes-203429801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ERYP","BK4139"],"gpt_icon":0},{"id":"2343890627","title":"Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2343890627","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2343890627?lang=en_us&edition=fundamental","pubTime":"2023-06-14 00:00","pubTimestamp":1686672000,"startTime":"0","endTime":"0","summary":"Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France. Listing markets: Euronext Paris from Euronext  & Nasdaq Global Select Market in the United-States Website : www.erytech.com. Gross voting rights number  is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.Without treasury shares.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monthly-information-related-total-number-160000177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2342506994","title":"ERYTECH Responds to Akkadian’s Disinformation","url":"https://stock-news.laohu8.com/highlight/detail?id=2342506994","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2342506994?lang=en_us&edition=fundamental","pubTime":"2023-06-12 13:00","pubTimestamp":1686546000,"startTime":"0","endTime":"0","summary":"Akkadian’s challenge of the merger is based on incomplete information and misleading arguments. Akkadian has not presented any valuable alternative option. Akkadian’s unfounded actions present a risk of destruction of shareholder value and loss of employment at two companies, and the potential loss of a strategically important technology in France. In this context, ERYTECH reminds its shareholders of the importance of participating in the Annual General Meeting on June 23 to support the proposed merger with PHERECYDES.Cambridge, MA  and Lyon , June 12, 2023, 7:00 am CEST – ERYTECH Pharma , today reacts to a series of disinformation attempts by Akkadian Partners to try and destabilize ERYTECH.On February 15, 2023, ERYTECH announced the strategic combination with PHERECYDES, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, with the ambition to create a global leader in extended phage therapy and accelerate the dev","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-responds-akkadian-disinformation-050000148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2341971014","title":"ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes","url":"https://stock-news.laohu8.com/highlight/detail?id=2341971014","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2341971014?lang=en_us&edition=fundamental","pubTime":"2023-06-05 14:00","pubTimestamp":1685944800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-announces-akkadian-initiated-proceedings-060000354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2338550183","title":"ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2338550183","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2338550183?lang=en_us&edition=fundamental","pubTime":"2023-05-25 04:05","pubTimestamp":1684958700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-announces-availability-documents-annual-200500295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BGC","ERYP","BK4139"],"gpt_icon":0},{"id":"2337991976","title":"ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes","url":"https://stock-news.laohu8.com/highlight/detail?id=2337991976","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2337991976?lang=en_us&edition=fundamental","pubTime":"2023-05-24 04:05","pubTimestamp":1684872300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-announces-availability-exemption-document-200500736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2336386858","title":"Monthly information related to total number of voting rights and shares composing the share capital _May 15, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2336386858","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2336386858?lang=en_us&edition=fundamental","pubTime":"2023-05-17 00:00","pubTimestamp":1684252800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monthly-information-related-total-number-160000904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2335814893","title":"ERYTECH Provides Update on the Announced Combination with PHERECYDES","url":"https://stock-news.laohu8.com/highlight/detail?id=2335814893","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2335814893?lang=en_us&edition=fundamental","pubTime":"2023-05-16 04:45","pubTimestamp":1684183500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-provides-announced-combination-pherecydes-204500969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2335822010","title":"Monthly information related to total number of voting rights  and shares composing the share capital _April 30, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2335822010","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2335822010?lang=en_us&edition=fundamental","pubTime":"2023-05-13 00:00","pubTimestamp":1683907200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monthly-information-related-total-number-160000389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2334321200","title":"Erytech Pharma Reported Cash And Cash Equivalents Of $33.7M At End Of March 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2334321200","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2334321200?lang=en_us&edition=fundamental","pubTime":"2023-05-09 17:10","pubTimestamp":1683623425,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/23/05/32281038/erytech-pharma-reported-cash-and-cash-equivalents-of-33-7m-at-end-of-march-2023","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERYP"],"gpt_icon":0},{"id":"2334525290","title":"Press Release: ERYTECH Provides Business and Financial Update for the First Quarter of 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2334525290","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2334525290?lang=en_us&edition=fundamental","pubTime":"2023-05-09 14:00","pubTimestamp":1683612000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4139","ERYP","R"],"gpt_icon":0},{"id":"2328282784","title":"ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2328282784","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2328282784?lang=en_us&edition=fundamental","pubTime":"2023-04-18 04:05","pubTimestamp":1681761900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/erytech-announces-approval-transfer-listing-200500844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","PSQ","QID","QQQ","TQQQ","BK4139","QLD","MNQmain","NQmain","ERYP",".IXIC"],"gpt_icon":0},{"id":"2327940993","title":"Monthly information related to total number of voting rights and shares composing the share capital _March 31, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2327940993","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2327940993?lang=en_us&edition=fundamental","pubTime":"2023-04-13 00:00","pubTimestamp":1681315200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UlbcTXpd1.otCAz4FC_QkQ--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7afc4e6ec0c62824da12d71dd35a65b8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monthly-information-related-total-number-160000369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ERYP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.erytech.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ERYTECH Pharma S.A., a biopharmaceutical company, focus on development of red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target the amino acid metabolism of cancer cells and induce tumor starvation. ERYTECH Pharma S.A. was incorporated in 2004 and is headquartered in Lyon, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.342642},{"month":2,"riseRate":0,"avgChangeRate":-0.142292},{"month":3,"riseRate":0.5,"avgChangeRate":-0.002279},{"month":4,"riseRate":0.5,"avgChangeRate":0.111025},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.1035},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.128142},{"month":7,"riseRate":0.2,"avgChangeRate":-0.022071},{"month":8,"riseRate":0,"avgChangeRate":-0.07038},{"month":9,"riseRate":0,"avgChangeRate":-0.189915},{"month":10,"riseRate":0.4,"avgChangeRate":-0.126938},{"month":11,"riseRate":0.6,"avgChangeRate":0.174813},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071321}],"exchange":"NASDAQ","name":"Erytech Pharma S.A.","nameEN":"Erytech Pharma S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Erytech Pharma S.A.(ERYP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Erytech Pharma S.A.(ERYP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Erytech Pharma S.A.,ERYP,Erytech Pharma S.A.股票,Erytech Pharma S.A.股票老虎,Erytech Pharma S.A.股票老虎国际,Erytech Pharma S.A.行情,Erytech Pharma S.A.股票行情,Erytech Pharma S.A.股价,Erytech Pharma S.A.股市,Erytech Pharma S.A.股票价格,Erytech Pharma S.A.股票交易,Erytech Pharma S.A.股票购买,Erytech Pharma S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Erytech Pharma S.A.(ERYP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Erytech Pharma S.A.(ERYP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction